IPC in MRI: The Effects of Preconditioning on Intramuscular High-Energy Phosphate Levels During Ischemia
Study Details
Study Description
Brief Summary
Ischemia reperfusion injury may be reduced by ischemic preconditioning. This projects aims to show the effects of short and long time ischemic preconditioning (both sequences 3 x 5 minutes) during and after an ischemic period of 20 minutes in healthy subjects by functional MRI. Ischemia is produces by cuff inflation to a suprasystolic pressure on one tight. Signal is acquired from calf muscles.
A cross-over design of 4 to 8 study periods is used, 4 different study days with 2 different MR measurement methods (BOLD imaging and high energy phosphates) are planned.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Other: 1 baseline MR signal prior to, during and 30 minutes after an ischemic period of 20 minutes |
Procedure: no preconditioning
no preconditioning
|
Other: 2 baseline MR signal prior to, during and 30 minutes after an ischemic period of 20 minutes with additional 5 minutes of cuff stenosis directly after cuff release |
Procedure: no preconditioning
no preconditioning
|
Other: 3 short time preconditioning, other details according arm 2 |
Procedure: preconditioning
3 times of five minutes ischemia, produced by cuff inflation to a suprasystolic pressure positioned on the thigh
|
Other: 4 long time preconditioning, other details according arm 2 |
Procedure: preconditioning
3 times of five minutes ischemia, produced by cuff inflation to a suprasystolic pressure positioned on the thigh
|
Outcome Measures
Primary Outcome Measures
- Change in cellular high energy phosphate levels and venous pH concentration for 31P MRS [during and 30 min after ischemia]
- Main outcome variables: Change in cellular oxygen saturation for BOLD MRI [during and 30 minutes after ischemia]
- Serum markers of myocellular injury (myoglobin, creatine-kinase) [prior to, directly and 24 hours after ischemia]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Men aged between 18 and 45 years
-
Nonsmoker for more than 3 months
-
Body mass index between 18 and 25 kg/m2
-
Normal findings in medical history and physical examination unless the investigator considers an abnormality to be clinically irrelevant
Exclusion Criteria:
-
Regular use of medication, abuse of alcoholic beverages, participation in a clinical trial in the 3 weeks preceding the study
-
Evidence of hypertension, pathologic hyperglycemia, hyperlipidemia
-
Treatment in the previous 3 weeks with any drug including over-the-counter drugs
-
Symptoms of a clinically relevant illness in the 2 weeks before the first study day
-
Blood donation during the previous 3 weeks
-
Any metallic, electric, electronic or magnetic device or object not removable
-
Claustrophobia
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Medical University of Vienna, Department of Clinical Pharmacology | Vienna | Austria | 1090 |
Sponsors and Collaborators
- Medical University of Vienna
Investigators
- Principal Investigator: Michael Wolzt, MD, MUV, Department of Clinical Pharmacology
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- IPC in MRI 040908